← Leaderboards
Jason J Rose
University Of Pittsburgh At Pittsburgh
$2,931,344
Attributed
$5,794,288
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1000K · FY2016–25$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,794,288 · 4
By mechanism
U01$2,994,043 · 1
R42$1,733,830 · 1
K08$969,880 · 1
F32$96,535 · 1
Top collaborators
- Karl V. Steiner3 shared
- Jesus Tejero Bravo3 shared
- David Joseph Weber3 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Jesus Tejero Bravo$3,879,160
- John Gorcsan$5,229,019
- Matthew Ryan Dent$900,832
- David Alan Greenberg$16,853,059
- Charleen T Chu$13,687,402
Others in their field
Top investigators on “Universities”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$507,483,583
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Jeffrey P Krischer · University Of South Florida$463,124,587
- Mitchell J Malone · Texas A&M Research Foundation$353,400,900
Research focus
UniversitiesProgramsMitochondriaUnited StatesMentorsCardiovascular SystemAntidotesTrainingLungCarbon Monoxide PoisoningCytochrome C OxidaseHeartBindingHemoglobinHyperbaric OxygenMitochondrial DysfunctionMouse ModelBusinessesCarbon MonoxideMortalityNeurocognitive DeficitErythrocytesAffinityIn Vivo
Grant awards (15)
University of Maryland BaltImore Life Science Discovery (UM-BILD) Accelerator$997,036
U01 · FY2025 · GM · contact PI
University of Maryland BaltImore Life Science Discovery (UM-BILD) Accelerator$997,036
U01 · FY2024 · GM · contact PI
University of Maryland BaltImore Life Science Discovery (UM-BILD) Accelerator$999,971
U01 · FY2023 · GM · contact PI
Hemoglobin-based antidotes for the treatment of carbon monoxide poisoning$734,942
R42 · FY2022 · ES
Discovering and Developing Recombinant Molecular Scavenging Agents for the Treatment of Carbon Monoxide Induced Cardiovascular Dysfunction$141,318
K08 · FY2022 · HL · contact PI
Discovering and Developing Recombinant Molecular Scavenging Agents for the Treatment of Carbon Monoxide Induced Cardiovascular Dysfunction$20,574
K08 · FY2022 · HL · contact PI
Hemoglobin-based antidotes for the treatment of carbon monoxide poisoning$748,895
R42 · FY2021 · ES
Discovering and Developing Recombinant Molecular Scavenging Agents for the Treatment of Carbon Monoxide Induced Cardiovascular Dysfunction$161,892
K08 · FY2021 · HL · contact PI
Hemoglobin-based antidotes for the treatment of carbon monoxide poisoning$249,993
R42 · FY2020 · ES
Discovering and Developing Recombinant Molecular Scavenging Agents for the Treatment of Carbon Monoxide Induced Cardiovascular Dysfunction$161,796
K08 · FY2020 · HL · contact PI
Developing a Low-Cost Intelligent Ventilator with Remote Control for Rapid, Global Deployment and Minimal Healthcare Provider Exposure$160,708
K08 · FY2020 · HL · contact PI
Discovering and Developing Recombinant Molecular Scavenging Agents for the Treatment of Carbon Monoxide Induced Cardiovascular Dysfunction$161,796
K08 · FY2019 · HL · contact PI
Discovering and Developing Recombinant Molecular Scavenging Agents for the Treatment of Carbon Monoxide Induced Cardiovascular Dysfunction$161,796
K08 · FY2018 · HL · contact PI
Carbon Monoxide Inhibition of Mitochondrial Function and Efficacy of a Novel Antidotal Therapeutic for Carbon Monoxide Poisoning$18,525
F32 · FY2017 · HL · contact PI
Carbon Monoxide Inhibition of Mitochondrial Function and Efficacy of a Novel Antidotal Therapeutic for Carbon Monoxide Poisoning$78,010
F32 · FY2016 · HL · contact PI